Muscle Relaxers for Teen Back Pain
Muscle relaxants can be used cautiously for short-term relief (≤2 weeks) in teenagers with acute back pain who have failed acetaminophen and NSAIDs, but they should not be first-line therapy and carry significant sedation risks that may be particularly problematic in adolescents.
Treatment Algorithm for Teen Back Pain
First-Line Approach
Start with acetaminophen or NSAIDs as initial pharmacologic therapy 1. NSAIDs provide moderate pain relief for acute low back pain with a small effect on disability 1, 2. However, acetaminophen shows no benefit for acute low back pain based on high-certainty evidence 3.
Second-Line: When to Consider Muscle Relaxants
Consider muscle relaxants only if:
- Pain persists after 3-5 days of NSAIDs
- Pain is severe enough to significantly impair function
- The teenager can tolerate sedation without impact on school/activities
- Treatment duration will be limited to ≤2 weeks maximum 2
Specific Agent Selection
If prescribing a muscle relaxant, choose based on this hierarchy:
Preferred Agents
- Cyclobenzaprine: Most studied with demonstrated efficacy for acute low back pain 2, 4, 5. Dose-related sedation but efficacy is independent of sedative effects 5.
- Metaxalone: Less sedating profile, though effectiveness evidence is more limited 4, 5.
Agents to Avoid in Teens
- Carisoprodol: Metabolized to meprobamate with significant abuse potential—particularly concerning in adolescents 1, 5
- Dantrolene: Black box warning for potentially fatal hepatotoxicity 1
- Benzodiazepines (e.g., diazepam): High abuse, addiction, and tolerance risks 1—especially problematic in teenagers
Critical Evidence Limitations
Important caveat: All muscle relaxant trials were conducted in adults, with treatment durations of ≤2 weeks (except one 3-week trial) 2. There is no pediatric-specific evidence for muscle relaxants in back pain. The evidence shows:
- Moderate-certainty evidence for small pain reduction at 2-4 days (RR 0.80) 2
- Very low-certainty evidence for acute low back pain showing small but not clinically important reductions 6
- No evidence supporting use beyond 2 weeks 2
- Recent high-quality evidence suggests muscle relaxants may provide no benefit over placebo when combined with NSAIDs 7
Safety Profile in Adolescents
Central nervous system adverse events are consistently reported 2:
- Sedation/drowsiness (most common)
- Dizziness
- Fatigue
The relative risk of adverse events is 1.5-2.0 times higher than placebo 2. In teenagers, these effects may significantly impair:
- School performance and attendance
- Driving safety
- Sports participation
- Cognitive function
Dosing Considerations
While specific pediatric dosing isn't established in the evidence, if prescribing:
- Start at the lowest effective adult dose
- Limit to 5-7 days initially, reassess before extending to maximum 14 days
- Counsel explicitly about sedation and avoiding driving/operating machinery
- Schedule follow-up within 1 week to assess response
When Muscle Relaxants Fail
If no improvement after a time-limited course (5-7 days), reassess and consider 1:
- Alternative diagnosis (red flags: fever, neurologic deficits, trauma history)
- Nonpharmacologic therapies: spinal manipulation for acute pain 1
- Referral for further evaluation rather than escalating to opioids
Bottom Line
The evidence for muscle relaxants in back pain is weak, adult-focused, and short-term only. In teenagers, the risk-benefit calculation tilts further toward caution given developmental concerns about sedation and substance abuse potential. Prioritize NSAIDs, limit muscle relaxant use to brief courses when truly necessary, and avoid agents with abuse potential entirely in this age group.